Next Article in Journal
A Fluorescence-Based Competitive Antibody Binding Assay for Kynurenine, a Potential Biomarker of Kidney Transplant Failure
Next Article in Special Issue
Semantic Segmentation of Extraocular Muscles on Computed Tomography Images Using Convolutional Neural Networks
Previous Article in Journal
Sonographic Evaluation of Muscle Echogenicity for the Detection of Intensive Care Unit-Acquired Weakness: A Pilot Single-Center Prospective Cohort Study
Previous Article in Special Issue
Cerebral Infarction and Evan’s Ratio on MRI Affect the Severity and Prognosis of Tuberculosis Meningitis Patients
 
 
Article
Peer-Review Record

Frequency and Consequences of Cervical Lymph Node Overstaging in Head and Neck Carcinoma

Diagnostics 2022, 12(6), 1377; https://doi.org/10.3390/diagnostics12061377
by Volker Hans Schartinger 1, Daniel Dejaco 1,*, Natalie Fischer 1, Anna Lettenbichler-Haug 1, Maria Anegg 1, Matthias Santer 1, Joachim Schmutzhard 1, Barbara Kofler 1, Samuel Vorbach 2, Gerlig Widmann 3 and Herbert Riechelmann 1
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Diagnostics 2022, 12(6), 1377; https://doi.org/10.3390/diagnostics12061377
Submission received: 2 May 2022 / Revised: 19 May 2022 / Accepted: 30 May 2022 / Published: 2 June 2022
(This article belongs to the Special Issue Head and Neck Imaging)

Round 1

Reviewer 1 Report

The topic is very important as patients with Head and Neck carcinoma have unfortunate outcomes and provide less time for extensive invasive therapy. Here are my comments to reshape the manuscript before considering it for publication: 

  • After the abstract, the authors only started talking about the fuzzy Matching Algorithm. However, I would recommend adding a section on it and all available algorithms and machine learning techniques for such studies. It can be a few lines but should be mentioned in the literature review.
  • In the discussion, please write a section on the strengths and weaknesses of the current study.

Author Response

Enclosed, please find our revised manuscript “Frequency and consequences of cervical lymph node overstaging in head and neck carcinoma” for possible publication in “Diagnostics”.

We appreciate the thoughtful review of our paper. We have changed and modified the manuscript accordingly. We shall address now the reviewer’s suggestions point by point:

Answers to comments of Reviewer 1:

The authors thank the reviewer for the helpful comments:

„The topic is very important as patients with Head and Neck carcinoma have unfortunate outcomes and provide less time for extensive invasive therapy. Here are my comments to reshape the manuscript before considering it for publication: 

  • After the abstract, the authors only started talking about the fuzzy Matching Algorithm. However, I would recommend adding a section on it and all available algorithms and machine learning techniques for such studies. It can be a few lines but should be mentioned in the literature review.“

The authors very much appreciate this valuable suggestion. However, we believe it is impossible to include all available machine learning techniques for fuzzy matching without severely compromising the integrity of the current manuscript.

Instead, we included a concise paragraph in the Discussion section, explaining the basic principle of fuzzy matching. Thus, frequently used traditional algorithms (e.g. Levenshtein Distance) and artificial intelligence based algorithms (e.g. fuzzy interference) were briefly introduced. In addition, we highlighted the reason for choosing a tradition fuzzy matching approach in more detail. In short, this choice was mainly based on the extensive number of data sets required for optimal matching accuracy if artificial intelligence based fuzzy matching would have been applied.

Please refer to the Discussion section of the revised manuscript, page 11, paragraph 3.

  • „In the discussion, please write a section on the strengths and weaknesses of the current study.“

We thank the reviewer for this suggestion. We have added a section in the revised manuscript on page 11, paragraph 2.

Author Response File: Author Response.pdf

Reviewer 2 Report

This manuscript reports the possible risk of overdiagnosis and overtreatment for cervical lymph node status of head and neck carcinoma. Many surgeons of OMS are probably aware of the risk of overtreatment, however, it has not been reported with evidence based on a certain number of patients. I think this manuscript will provide new insights into diagnosis which will lead to sophistication of treatment strategy.

Someone thinks that this can be accepted without any correction, however, I’d like to offer some minor considerations especially for readers in non-European countries where the treatment strategy (including devices for diagnosis and treatment) is quite different.

 

Minor point:

  1. In lines 51-60, there are four questions. Each question will be clearly visualized and understood if the line would be changed.
  2. Two groups compared in this manuscript, patients with treatment de-escalation and patients with primary RT may be difficult to understand for readers in non-European countries. View of life is totally different between Western countries and Asian/Middle-east countries which may affect the treatment strategy. Moreover, a set of CT scanning, PET-CT, and needle biopsy is completely performed in some Asian countries, and their first treatment strategy is surgical treatment. Therefore, I recommend you clarify the definition of the two compared groups with easy words.

Author Response

Enclosed, please find our revised manuscript “Frequency and consequences of cervical lymph node overstaging in head and neck carcinoma” for possible publication in “Diagnostics”.

We appreciate the thoughtful review of our paper. We have changed and modified the manuscript accordingly. We shall address now the reviewer’s suggestions point by point:

Answers to comments of Reviewer 2:

This manuscript reports the possible risk of overdiagnosis and overtreatment for cervical lymph node status of head and neck carcinoma. Many surgeons of OMS are probably aware of the risk of overtreatment, however, it has not been reported with evidence based on a certain number of patients. I think this manuscript will provide new insights into diagnosis which will lead to sophistication of treatment strategy.

Someone thinks that this can be accepted without any correction, however, I’d like to offer some minor considerations especially for readers in non-European countries where the treatment strategy (including devices for diagnosis and treatment) is quite different.

Minor point:

  • In lines 51-60, there are four questions. Each question will be clearly visualized and understood if the line would be changed.

We thank the reviewer for this suggestion. We have changed accordingly in the revised manuscript.

  • Two groups compared in this manuscript, patients with treatment de-escalation and patients with primary RT may be difficult to understand for readers in non-European countries. View of life is totally different between Western countries and Asian/Middle-east countries which may affect the treatment strategy. Moreover, a set of CT scanning, PET-CT, and needle biopsy is completely performed in some Asian countries, and their first treatment strategy is surgical treatment. Therefore, I recommend you clarify the definition of the two compared groups with easy words.

We thank the reviewer for this interesting comment. We have addressed this point in the revised manuscript on page 7, paragraph 4 and page 11, paragraph 2.

Author Response File: Author Response.pdf

Back to TopTop